Last updated 2026-07-20
- Acquired by Guardant Health for $150M, Feb 2026
- Raised $8M Series A led by aMoon Fund, Oct 2024
- Raised Seed round led by aMoon Fund, Mar 2022
Total raised
$8.0M
Last: Undisclosed Round 2024-11
Stage
Acquired
Founded
2020
Headcount
20
HQ
Rehovot, Israel
Sector
Health Tech & Life Sciences
About
MetaSight Diagnostics is a health technology company specializing in advanced blood-based testing technologies for early disease detection. The company utilizes proprietary, cost-effective mass spectrometry technologies (metabolomics, lipidomics, and proteomics) to create affordable and precise liquid biopsy diagnostics for early detection of a variety of chronic and acute diseases. Their approach leverages a large clinico multi-omics database, integrating molecular datasets with electronic health records to develop accurate non-invasive diagnostic tests. MetaSight's platform can be used for various pathologies including cancer, metabolic diseases, autoimmunity, and neurodegenerative disorders.
Funding history · 2 rounds · $8.0M total
2024-10
A Round
$8.0M
★ aMoon Fund★ Arc Ventures★ Saban Ventures★ Alumni Ventures
2022-03
Seed
Undisclosed
★ aMoon Fund
Headcount over time
From 6 (2022-08) to 23 (2026-01) · +17 (+283%) · 11 points · source: Finder history + radar grounding
Q&A
- What is MetaSight Diagnostics' primary focus?
- MetaSight Diagnostics is focused on revolutionizing liquid biopsy by developing and deploying accurate, affordable, and accessible diagnostics for diverse diseases through a single blood test, applicable for population scale screening.
- When was MetaSight Diagnostics founded?
- MetaSight Diagnostics was founded in April 2020.
- What is the current status of MetaSight Diagnostics?
- MetaSight Diagnostics is currently active and was acquired by Guardant Health in February 2026.
- How many employees does MetaSight Diagnostics have?
- MetaSight Diagnostics has 11-50 employees.
- What was MetaSight Diagnostics' most recent funding round?
- In November 2024, MetaSight Diagnostics raised $8,000,000. Investors included Saban Ventures and aMoon Fund.
- What is MetaSight Diagnostics' total funding raised to date?
- MetaSight Diagnostics has raised a total of $8,000,000.
- Which sector does MetaSight Diagnostics primarily operate in?
- MetaSight Diagnostics' primary sector is Health Tech & Life Sciences.
- Where is MetaSight Diagnostics headquartered?
- MetaSight Diagnostics is headquartered in Rehovot, Israel.
Team · 1
Prof. Tomer Shlomi
Founder · Founder and CEO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyTest Diagnostics & Screening
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticals
Business model
B2B
Tags
spectroscopyoncologydiagnosticspharmaceuticalsbiopsybiotechnologyinflammatory-diseasesblood-testbiomarkers
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | metasightdx.com |
|---|---|
| linkedin.com/company/82976943 |
Identifiers & details
| Legal name | MetaSight Diagnostics Ltd. |
|---|---|
| Founded | 2020-4 |
| Employees (exact) | 20 |
| Status reason | Acquired by Guardant Health on Feb 2026 |
Acquisitions & public offerings
Acquired by Guardant Health 2026-02 $150.0M
Radar intelligence
Patents
| EPO | 2 |
|---|
Web history (Wayback)
| Domain | metasightdx.com |
|---|
Certificate / subdomain footprint
| Subdomains | 4 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516187796 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2020-04-30 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 1 |
| Registry events | 8 — name_change (1), other (1), shares_capital (2), people (3), charge (1) |
| Name changes | 2026-03-25 |
| Registered address | הולצמן חיים 2 רחובות |
Recent registry events
| Date | Event |
|---|---|
| 2026-03-25 | שינוי שם |
| 2026-05-18 | שינוי בתקנון |
| 2026-05-17 | שינוי בהרכב הון - מניות-שינוי סוג מניה |
| 2026-05-10 | העברת מניות |
| 2026-05-10 | עדכון דירקטורים-הסרת דירקטור |
| 2026-03-10 | עדכון בעלי תפקידים |
| 2026-05-06 | עדכון דירקטורים-הוספת דירקטור |
| 2026-05-05 | רישום שעבוד |